Breast cancer in African-American women: differences in tumor biology from European-American women.
暂无分享,去创建一个
[1] D. Miglioretti,et al. Does Utilization of Screening Mammography Explain Racial and Ethnic Differences in Breast Cancer? , 2006, Annals of Internal Medicine.
[2] C. Perou,et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.
[3] Zhao Chen,et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.
[4] L. Newman,et al. Breast cancer in sub‐Saharan Africa: How does it relate to breast cancer in African‐American women? , 2005, Cancer.
[5] J. Cunningham,et al. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis , 2004, Breast Cancer Research and Treatment.
[6] L. Newman. Breast carcinoma in African‐American and White women , 2004, Cancer.
[7] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[8] C. Perou,et al. Race and the poor prognosis basal breast tumor (BBT) phenotype in the population-based Carolina Breast Cancer Study (CBCS). , 2004, Journal of Clinical Oncology.
[9] R. Coates,et al. Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma , 2004, Cancer.
[10] William D. Foulkes,et al. Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer , 2004 .
[11] S. Joslyn. Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival , 2002, Breast Cancer Research and Treatment.
[12] R. Millikan,et al. Tumor characteristics in African American and white women , 2001, Breast Cancer Research and Treatment.
[13] J. Cunningham,et al. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis , 2004, Breast Cancer Research and Treatment.
[14] L. Bégin,et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. , 2004, Journal of the National Cancer Institute.
[15] A. Ellis. Breast , 2002, BMJ : British Medical Journal.
[16] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Malone,et al. Differences in breast cancer stage, treatment, and survival by race and ethnicity. , 2003, Archives of internal medicine.
[19] J. Baselga,et al. HER-Targeted Tyrosine-Kinase Inhibitors , 2002, Oncology.
[20] J. Baselga. Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] B. Hankey,et al. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. , 2002, American journal of epidemiology.
[22] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[23] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[25] C. C. Johnson,et al. Race and differences in breast cancer survival in a managed care population. , 1999, Journal of the National Cancer Institute.
[26] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[27] S. Gapstur,et al. Hormone receptor status of breast tumors in black, Hispanic, and non‐Hispanic white women: An analysis of 13,239 cases , 1996, Cancer.
[28] G M Clark,et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. , 1994, Journal of the National Cancer Institute.
[29] C. Redmond,et al. Histological characteristics of breast carcinoma in blacks and whites. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] C. Osborne,et al. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[32] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[33] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.